1. United States Food and Drug Administration Circulatory System Devices Panel Meeting. https://www.fda.gov/advisory-committees/advisory-committee-calendar/december-4-5-2018-circulatory-system-devices-panel-medical-devices-advisory-committee-meeting#event-materials. Accessed July 01, 2019.
2. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2018;138:e426-e483. 2017 Guidelines.
3. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study;Krum;Lancet,2009
4. Renal sympathetic denervation in patients with treatment-resistant hypertension (the Symplicity HTN-2 trial): a randomised controlled trial. Symplicity HTN-2 investigators;Esler;Lancet,2010
5. Bakris GL; SYMPLICITY HTN-3 investigators. A controlled trial of renal denervation for resistant hypertension;Bhatt;N Engl J Med,2014